|
SUMMARY OF CRITICAL ACCOUNTING POLICIES AND USE OF ESTIMATES (Details)
|
9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Shares underlying, outstanding | 28,591,140 | 16,536,916 | 16,528,739 | 13,441,310 |
| Employee Stock Option [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Shares underlying, outstanding | 8,425,095 | 6,011,023 | 6,050,623 | 4,674,628 |
| Warrant [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Shares underlying, outstanding | 19,897,928 | 10,266,597 | 10,216,597 | 8,513,984 |
| Convertible Notes Payable [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Shares underlying, outstanding | 268,117 | 259,296 | 261,519 | 252,698 |